NIH and BARDA Statement on FDA Emergency Use Authorization for Janssen COVID-19 Vaccine, February 27, 2021
FDA Johnson & Johnson Vaccine: As Advisers Recommend Approving 1-Shot Option, COVID Spike Remains Balanced